Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Cardiovascular & Haematological Disorders - Drug Targets
  4. Fast Track Articles
  5. Fast Track Article
image of Diagnostic Challenges of Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome: A Rare Case Report and Review of the Literature

Abstract

Introduction

POEMS syndrome is a rare multisystem disorder associated with plasma cell dyscrasia and abnormal cytokine production, including vascular endothelial growth factor (VEGF). The mandatory criterion for its diagnosis includes polyneuropathy and monoclonal plasma cell disorder, along with other major and minor criteria. This case highlights the diagnostic and therapeutic challenges of POEMS syndrome by depicting the case of a 61-year-old male with progressive sensory-motor polyneuropathy, lymphadenopathy, and splenomegaly.

Case Presentation

The patient presented with a year-long history of bilateral limb weakness and sensory disturbances, accompanied by abdominal distention, weight loss, and other systemic symptoms. Clinical examination revealed skin hyperpigmentation, splenomegaly, and a right axillary lymph node enlargement. Neurological evaluation showed distal limb hypotonia, absent reflexes, and sensory deficits. Diagnostic investigations, including nerve conduction studies, imaging, and bone marrow biopsy, confirmed POEMS syndrome based on polyneuropathy, monoclonal IgG lambda plasma cells, Castleman disease, sclerotic bone lesions, elevated VEGF, and minor criteria, such as endocrinopathy and skin changes. The treatment comprised lenalidomide and dexamethasone, resulting in significant improvement at the three-month follow-up, including normalized VEGF levels and resolution of ascites.

Conclusion

This case highlights the necessity of identifying the many presentations of POEMS syndrome for prompt diagnosis and treatment. Despite its rarity and diagnostic complexity, prompt treatment can significantly improve clinical outcomes. POEMS syndrome should be considered in patients with unexplained neuropathy and systemic features, enabling better outcomes through targeted therapies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chddt/10.2174/011871529X352283250305042317
2025-03-13
2025-05-11

  • From This Site

    /content/journals/chddt/10.2174/011871529X352283250305042317
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Dispenzieri A. POEMS Syndrome: 2019 Update on diagnosis, risk‐stratification, and management. Am. J. Hematol. 2019 94 7 812 827 10.1002/ajh.25495 31012139
    [Google Scholar]
  2. Dispenzieri A. POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management. Am. J. Hematol. 2021 96 7 872 888 10.1002/ajh.26240 34000085
    [Google Scholar]
  3. Bardwick P.A. Zvaifler N.J. Gill G.N. Newman D. Greenway G.D. Resnick D.L. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980 59 4 311 322 10.1097/00005792‑198007000‑00006 6248720
    [Google Scholar]
  4. Takatsuki K. Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: Clinical and laboratory features of 109 reported cases. Jpn. J. Clin. Oncol. 1983 13 3 543 555 6315993
    [Google Scholar]
  5. Nakanishi T. Sobue I. Toyokura Y. Nishitani H. Kuroiwa Y. Satoyoshi E. Tsubaki T. Igata A. Ozaki Y. The Crow‐Fukase syndrome. Neurology 1984 34 6 712 720 10.1212/WNL.34.6.712 6539431
    [Google Scholar]
  6. Singh D. Wadhwa J. Kumar L. Raina V. Agarwal A. Kochupillai V. POEMS syndrome: Experience with fourteen cases. Leuk. Lymphoma 2003 44 10 1749 1752 10.1080/1042819031000111044 14692529
    [Google Scholar]
  7. Zhang B. Song X. Liang B. Hou Q. Pu S. Ying J.R. Gao C. The clinical study of POEMS syndrome in China. Neuroendocrinol. Lett. 2010 31 2 229 237 20424579
    [Google Scholar]
  8. Kanuganti D. Nagarjunakonda V.S. Bandarupalli P. Gorijala V.K. Konagalla V.L.S.R. Kowtha P. POEMS syndrome: A case report and review of the literature. Cureus 2022 14 7 e27001 10.7759/cureus.27001 35989837
    [Google Scholar]
  9. Keddie S. Lunn M.P. POEMS syndrome. Curr. Opin. Neurol. 2018 31 5 551 558 10.1097/WCO.0000000000000610 30138145
    [Google Scholar]
  10. D’Souza A. Hayman S.R. Buadi F. Mauermann M. Lacy M.Q. Gertz M.A. Kyle R.A. Kumar S. Greipp P.R. Lust J.A. Russell S.J. Zeldenrust S. Dingli D. Witzig T.E. Rajkumar S.V. Dispenzieri A. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 2011 118 17 4663 4665 10.1182/blood‑2011‑06‑362392 21881050
    [Google Scholar]
  11. Li J. Zhou D. New advances in the diagnosis and treatment of POEMS syndrome. Br. J. Haematol. 2013 161 3 303 315 10.1111/bjh.12236 23398538
    [Google Scholar]
  12. van Rhee F. Stone K. Szmania S. Barlogie B. Singh Z. Castleman disease in the 21st century: An update on diagnosis, assessment, and therapy. Clin. Adv. Hematol. Oncol. 2010 8 7 486 498 20864917
    [Google Scholar]
  13. Warsame R. Yanamandra U. Kapoor P. POEMS Syndrome: An Enigma. Curr. Hematol. Malig. Rep. 2017 12 2 85 95 10.1007/s11899‑017‑0367‑0 28299525
    [Google Scholar]
  14. Cook G. Iacobelli S. van Biezen A. Ziagkos D. LeBlond V. Abraham J. McQuaker G. Schoenland S. Rambaldi A. Halaburda K. Rovira M. Sica S. Byrne J. Sanz R.G. Nagler A. van de Donk N.W.C.J. Sinisalo M. Cook M. Kröger N. De Witte T. Morris C. Garderet L. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the chronic malignancy working party of the european society for blood & marrow transplantation. Haematologica 2017 102 1 160 167 10.3324/haematol.2016.148460 27634201
    [Google Scholar]
  15. Cerri F. Falzone Y.M. Riva N. Quattrini A. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome. J. Neurol. 2019 266 1 258 267 10.1007/s00415‑018‑9068‑4 30264176
    [Google Scholar]
  16. Dumas C. Bienvenu F.H. Hicks J. Weber E. Sève P. Thrombosis revealing POEMS syndrome. About a case. Ann. Biol. Clin. 2020 78 2 195 197 10.1684/abc.2020.1534 32162605
    [Google Scholar]
  17. Mehta S. Rajan R. Wilson V. Das B. Singh P. Ahluwalia J. Lal V. Stroke and POEMS syndrome: More than a chance association. Neurol. India 2016 64 6 1318 1319 10.4103/0028‑3886.193842 27841210
    [Google Scholar]
  18. Kourelis T.V. Buadi F.K. Kumar S.K. Gertz M.A. Lacy M.Q. Dingli D. Go R.S. Kapoor P. Lust J.A. Hayman S.R. Hwa Y. Rajkumar S.V. Zeldenrust S.R. Russell S.J. Lin Y. Leung N. Kyle R.A. Gonsalves W.I. Dispenzieri A. Long‐term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience. Am. J. Hematol. 2016 91 6 585 589 10.1002/ajh.24356 26972803
    [Google Scholar]
  19. Singh J. Atam V. Dinkar A. Acute onset sensory polyneuropathy due to metronidazole therapy. J. Assoc. Physicians India 2015 63 9 87 88 27608880
    [Google Scholar]
/content/journals/chddt/10.2174/011871529X352283250305042317
Loading
Diagnostic Challenges of Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome: A Rare Case Report and Review of the Literature
Bentham Science Publishers ; https://doi.org/10.2174/011871529X352283250305042317
/content/journals/chddt/10.2174/011871529X352283250305042317
/content/journals/chddt/10.2174/011871529X352283250305042317
Loading

Data & Media loading...


  • Article Type:     Case Report
Keywords: castleman disease ; plasma cell neoplasm ; Paraneoplastic syndrome ; organomegaly ; polyneuropathy ; endocrinopathy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test